Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

Importance Atrial fibrillation (AF) affects 34 million people worldwide and is a leading cause
of stroke. A readily accessible means to continuously monitor for AF could prevent large …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …

Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Objective It is not known whether patients with atrial fibrillation (AF) with ischemic stroke
despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how …

Importance Although non–vitamin K antagonist oral anticoagulants (NOACs) are
increasingly used to prevent thromboembolic disease, there are limited data on NOAC …

Objective The aim was to evaluate, in patients with atrial fibrillation (AF) and acute ischemic
stroke, the association of prior anticoagulation with vitamin K antagonists (VKAs) or direct …